Recent News About Merck
-
'Welcome news for patients': NJ and Japanese companies achieve cancer treatment milestone
The European Commission approved Keytruda and Lenvima to start anti-cancer treatment after a study showed this drug combo gave patients a better chance at overall survival than chemotherapy.